Tulen J H, Mulder G, Pepplinkhuizen L, Man in 't Veld A J, van Steenis H G, Moleman P
Department of Psychiatry, University Hospital Rotterdam Dijkzigt, The Netherlands.
Psychopharmacology (Berl). 1994 Feb;114(1):81-9. doi: 10.1007/BF02245447.
Dose-dependent effects of intravenously administered lorazepam on haemodynamic fluctuations were studied by means of spectral analysis, in order to elucidate sympathetic and parasympathetic components in cardiovascular control during situations of rest and mental stress after benzodiazepine administration. In a double-blind randomized cross-over study, nine male volunteers participated in two sessions: a placebo and lorazepam session. During these sessions, the subjects repeatedly performed a 10-min version of the Stroop Color Word Test (CWT), with 10 min of rest between the CWTs. Lorazepam was administered before each rest period in increasing doses of 0.0, 0.06, 0.13, 0.25 and 0.5 mg (total cumulative dose: 0.94 mg). During the placebo session the subjects received five placebo injections. For five of the nine subjects the lorazepam session was their first session. Heat rate (HR), blood pressure (BP) and respiration were recorded continuously. Power spectra were calculated per 2.5-min periods for HR, systolic (SBP) and diastolic BP (DBP). Spectral density was assessed for three frequency bands: low (LFB: 0.02-0.06 Hz), mid (MFB: 0.07-0.14 Hz) and high (HFB: 0.15-0.40 Hz). During the consecutive periods of rest, lorazepam induced a dose-dependent decrease in HR, and a dose-dependent increase in LFB, MFB and HFB power of HR, but lorazepam had no effect on BP. The effects were significant after 0.44 mg lorazepam for HR and HFB power, and after 0.94 mg lorazepam for the HR fluctuations in the LFB and MFB. Lorazepam did not influence the cardiovascular responses to the CWT.(ABSTRACT TRUNCATED AT 250 WORDS)
通过频谱分析研究静脉注射劳拉西泮对血流动力学波动的剂量依赖性影响,以阐明苯二氮䓬给药后休息和精神应激状态下心血管控制中的交感神经和副交感神经成分。在一项双盲随机交叉研究中,9名男性志愿者参加了两个阶段:安慰剂阶段和劳拉西泮阶段。在这些阶段中,受试者反复进行10分钟版本的斯特鲁普色词测验(CWT),两次CWT之间休息10分钟。在每个休息期之前,以0.0、0.06、0.13、0.25和0.5毫克(总累积剂量:0.94毫克)的递增剂量给予劳拉西泮。在安慰剂阶段,受试者接受了五次安慰剂注射。9名受试者中有5名的劳拉西泮阶段是他们的第一个阶段。连续记录心率(HR)、血压(BP)和呼吸。每2.5分钟计算一次HR、收缩压(SBP)和舒张压(DBP)的功率谱。评估三个频段的频谱密度:低频(LFB:0.02 - 0.06赫兹)、中频(MFB:0.07 - 0.14赫兹)和高频(HFB:0.15 - 0.40赫兹)。在连续的休息期内,劳拉西泮导致HR剂量依赖性降低,以及HR的LFB、MFB和HFB功率剂量依赖性增加,但劳拉西泮对BP无影响。劳拉西泮剂量达到0.44毫克时对HR和HFB功率的影响显著,达到0.94毫克时对LFB和MFB中的HR波动影响显著。劳拉西泮不影响对CWT的心血管反应。(摘要截断于250字)